Overview

Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the relationship between genotype variations and clinical phenotype in patients with congenital nephrogenic diabetes insipidus.
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborator:
Northwestern University
Treatments:
Arginine Vasopressin
Chlorothiazide